Business Context and Reporting Period
This Form 8-K is a current report filed by Virios Therapeutics, Inc. (not Dogwood Therapeutics, Inc., as indicated in the metadata) on September 18, 2023. The registrant is a Delaware corporation with its principal executive offices in Alpharetta, GA, and its common stock trades on the Nasdaq Capital Market under the symbol VIRI.
Key Financial Metrics
This filing does not contain periodic financial statements (e.g., revenue, profit, cash flow, or margins). The only financial metric disclosed relates to a terminated financing arrangement:
- Capital on Demand Sales Agreement: The Company had an agreement to offer and sell shares with aggregate proceeds of up to $6.7 million.
- Utilization: No sales were made under this agreement since August 9, 2023.
- Termination Penalties: The Company is not subject to any termination penalties.
Material Changes
The primary material event reported is the termination of a Material Definitive Agreement:
- Action: Virios Therapeutics, Inc. provided notice on September 18, 2023, to terminate the Capital on Demand Sales Agreement with JonesTrading Institutional Services LLC.
- Effective Date: The termination is effective September 28, 2023.
- Future Activity: The Company does not plan to make any sales under the agreement prior to the effective termination date.
Guidance, Outlook, and Risks
The filing does not provide updated financial guidance, management commentary on future operations, or specific risk factors beyond the termination of the sales agreement. The document notes that a press release announcing the termination was issued on the same date and is attached as Exhibit 99.1.
Investor Verification Checklist
- Verify the company name discrepancy: The filing is for Virios Therapeutics, Inc., not Dogwood Therapeutics, Inc.
- Confirm the effective termination date of the $6.7 million sales agreement is September 28, 2023.
- Review the attached press release (Exhibit 99.1) for any additional context on the decision to terminate the financing facility.
- Check recent trading activity to confirm no shares were sold under the agreement after August 9, 2023.